Peter G. Schultz

Peter G. Schultz ( born June 23, 1956 in Cincinnati, Ohio) is an American chemist.

Life and work

Schultz studied chemistry at the California Institute of Technology (Caltech ) in 1979 and earned his Bachelor of Science degree summa cum laude in 1984 and his Ph.D. under the supervision of Peter Dervan. His thesis is entitled Ground and Excited State Studies of 1,1- Diazenes / Design of Sequence Specific DNA Cleaving Molecules. Subsequently, he was post- doctoral fellow with Christopher Walsh at the Massachusetts Institute of Technology, in 1985 to go to the University of California, Berkeley, where he 1985-1987 Assistant Professor, 1987-1989 Associate Professor and from 1989 to 1999 full professor at the Faculty of Chemistry had. In addition, he was from 1985 to 2003, researchers at Lawrence Berkeley National Laboratory, and from 1994 to 1999 also at the Howard Hughes Medical Institute. Since 1999 he has been Professor of Chemistry at the Scripps Research Institute.

Schultz worked in the border area between organic chemistry and chemical biology. In particular, he creates highly efficient catalytic antibodies and research on stem cells and non-natural amino acids. Also it uses combinatorial methods, such as cDNA - libraries and microarray to create materials with new properties. He has published more than 400 scientific papers.

In November 2009, Schultz was forced to withdraw from 2004, which described how a number of other publications from his group of researchers a method for the expression of glycosylated proteins with amino acids in E. coli, a much-cited Science paper. This was first referred to as pharmaceutical "killer application", probably received over 300 million dollars from the economy for Schultz. It was his staff not able to reproduce the experimental results or to produce, the corresponding laboratory records.

Awards

Memberships

643676
de